Allogenic Amniotic Tissue Injections

Allogenic amniotic tissue injections are created from tissue from another person that has been frozen. Frozen tissue is dead tissue and therefore contains no live stem cells, which independent lab tests have confirmed.

Despite this, and the fact that none of the manufacturers of amniotic tissue claim that there are living stem cells in their products, there has been an explosion in the amount of providers advertising so-called “amniotic stem cell” injections.

Here are five key points

  • Some physicians inject allogenic dead tissue into patients while claiming that they are injecting amniotic stem cells.
  • The placental tissue-derived products tested by the Interventional Orthopedics Foundation (IOF) are FDA regulated and sold directly to physician practices. Although not registered as live stem cell products, many physician websites tout the tissues as “stem cell therapy.”
  • Although these allogenic products contain no live stem cells, they exhibit a weak growth factor effect, which can help promote tissue repair. Therefore, patients may experience some improvement after these injections.
  • Growth factors can be obtained at a less expensive price and physicians should not be billing for stem cell therapy when injecting these dead tissue products into patients.
  • The IOF encourages physicians to use platelet rich plasma and bone marrow concentrate for biologic therapies. These are autologous treatments.